Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFORTcombo: High Protein in Critical Illness
NCT04012333Phase 3Withdrawn
- Sponsor
- RWTH Aachen University
- Start
- Jun 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of l-leucine in critical illness, Malnutrition, sponsored by RWTH Aachen University. Planned start Jun 2020; status: withdrawn.
02
Drugs
l-leucine
03
Conditions
critical illnessMalnutrition
Beyond the preview
Go deeper on NCT04012333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04012333.